// App-Quantinova.ai

: Cardiometabolic Disease Protein Signatures and Response to GLP-1 Receptor Agonist in the EXSCEL Clinical Trial

Researchers

Presenter

  • Rachel Ostroff

Principal Investigators

  • Jennifer Green

  • Robert J Mentz

  • Jessica Chadwick

  • Michael Hinterberg

  • Natasha Kureshi

  • Missy Simpson

  • Stephen A Williams

  • Adrian F Hernandez

  • Rury Holman

  • Naveed Sattar

  • Svati H Shah

Medical Centers

  • Clinical R&D, SomaLogic, Inc., Boulder, CO

  • Duke Univ Med Cntr, Hillsborough, NC

  • Duke Clinical Research Institute, Durham, NC

  • Univ of Glasgow, Glasgow

  • SomaLogic, Boulder, CO

  • Duke Hosp, Durham, NC

  • Univ of Oxford, Oxford

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Nucleoside diphosphate kinase A

Drug/Treatment

  • Exenatide

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Open Label

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved